Dr. Cynthia Ann Lemere is a Professor of Neurology at the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital and Harvard Medical School in Boston. After receiving her Ph.D., she remained at the CND as a Postdoctoral Fellow and Instructor. She serves on several national and international scientific advisory boards, including the ADPD Scientific Advisory Council, the Brightfocus Foundation Scientific Review Council, the National Alzheimer’s Association Medical and Scientific Advisory Council, and the DIAN-TU Therapeutic Evaluation Committee. In addition, she serves as a scientific advisor for several companies. Her research focuses on using the immune system therapeutically for the treatment of Alzheimer's disease. Studies out of her lab explore the role of immune system proteins in Alzheimer's and the clearance of amyloid-beta from the brain, as well as gaining a better understanding of the development and progression of Alzheimer’s disease in Down syndrome; identifying the risks of deep space radiation on the brain; and understanding the contributions of a disease-related, modified form of amyloid-beta, called pyroglutamate amyloid-beta, to Alzheimer’s disease and determining its value as a therapeutic target.
